AAAAAA
Results:
1-15
|
Results: 15
Authors:
Peters, FPJ
Fickers, MMF
Erdkamp, FLG
Wals, J
Wils, JAJM
Schouten, HC
Citation: Fpj. Peters et al., The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates, ANN HEMATOL, 80(7), 2001, pp. 406-410
Authors:
Peters, FPJ
Lalisang, RI
Fickers, MMF
Erdkamp, FLG
Wils, JAJM
Houben, SGJ
Wals, J
Schouten, HC
Citation: Fpj. Peters et al., Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study, ANN HEMATOL, 80(3), 2001, pp. 155-159
Authors:
van de Poel, MHW
Pasman, PC
Schouten, HC
Citation: Mhw. Van De Poel et al., The use of thalidomide in chronic refractory graft versus host disease, NETH J MED, 59(2), 2001, pp. 45-49
Authors:
Schouten, HC
Kvaloy, S
Sydes, M
Qian, W
Fayers, PM
Citation: Hc. Schouten et al., The CUP trial: A randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL), ANN ONCOL, 11, 2000, pp. 91-94
Authors:
Schouten, HC
Citation: Hc. Schouten, High-dose therapy for follicular lymphoma - The Freedman/Friedberg/Gribbenarticle reviewed, ONCOLOGY-NY, 14(3), 2000, pp. 330-331
Authors:
Stevens-Kroef, MJPL
Dirckx, R
Meers, LEC
Albrechts, JCM
Schouten, HC
Hamers, AJH
Citation: Mjpl. Stevens-kroef et al., Complex chromosome 9, 20, and 22 rearrangements in acute lymphoblastic leukemia with duplication of BCR and ABL sequences, CANC GENET, 116(2), 2000, pp. 119-123
Authors:
Lalisang, RI
Voest, EE
Wils, JA
Nortier, JW
Erdkamp, FL
Hillen, HF
Wals, J
Schouten, HC
Blijham, GH
Citation: Ri. Lalisang et al., Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer, BR J CANC, 82(12), 2000, pp. 1914-1919
Authors:
Peters, FPJ
Ten Haaft, MA
Schouten, HC
Citation: Fpj. Peters et al., Intermediate and high grade non-Hodgkin's lymphoma in the elderly, LEUK LYMPH, 33(3-4), 1999, pp. 243-252
Authors:
Hoeve, MA
Gisbertz, IAM
Schouten, HC
Schuuring, E
Bot, FJ
Hermans, J
Hopman, A
Kluin, P
Arends, JW
van Krieken, JHJM
Citation: Ma. Hoeve et al., Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy, LEUKEMIA, 13(5), 1999, pp. 799-807
Authors:
Arends, JE
Bot, FJ
Gisbertz, IAM
Schouten, HC
Citation: Je. Arends et al., Expression of CD10, CD75 and CD43 in MALT lymphoma and their usefulness indiscriminating MALT lymphoma from follicular lymphoma and chronic gastritis, HISTOPATHOL, 35(3), 1999, pp. 209-215
Authors:
Vellenga, E
van Putten, WLJ
Boogaerts, MA
Daenen, SMGJ
Verhoef, GEG
Hagenbeek, A
Jonkhoff, AR
Huijgens, PC
Verdonck, LF
van der Lelie, J
Schouten, HC
Gmur, J
Wijermans, P
Gratwohl, A
Hess, U
Fey, MF
Lowenberg, B
Citation: E. Vellenga et al., Peripheral blood stem cell transplantation as an alternative to autologousmarrow transplantation in the treatment of acute myeloid leukemia?, BONE MAR TR, 23(12), 1999, pp. 1279-1282
Authors:
Socie, G
Stone, JV
Wingard, JR
Weisdorf, D
Henslee-Downey, PJ
Bredeson, C
Cahn, JY
Passweg, JR
Rowlings, PA
Schouten, HC
Kolb, HJ
Klein, JP
Citation: G. Socie et al., Long-term survival and late deaths after allogeneic bone marrow transplantation, N ENG J MED, 341(1), 1999, pp. 14-21
Authors:
Jansen, MPHM
Hopman, AHN
Bot, FJ
Haesevoets, A
Stevens-Kroef, MJPL
Arends, JW
Jox, A
Wolf, J
Ramaekers, FCS
Schouten, HC
Citation: Mphm. Jansen et al., Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: The progenitor cell of the malignant clone?, J PATHOLOGY, 189(4), 1999, pp. 527-532
Authors:
Segeren, CM
Sonneveld, P
van der Holt, B
Baars, JW
Biesma, DH
Cornellissen, JJ
Croockewit, AJ
Dekker, AW
Fibbe, WE
Lowenberg, B
Kooy, MV
van Oers, MHJ
Richel, DJ
Schouten, HC
Vellenga, E
Verhoef, GEG
Wijermans, PW
Wittebol, S
Lokhorst, HM
Citation: Cm. Segeren et al., Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma, BR J HAEM, 105(1), 1999, pp. 127-130
Relevance of the expression of Bcl-2 in combination with p53 as a prognostic factor in breast cancer
Authors:
Jansen, RLH
Joosten-Achjanie, SR
Volovics, A
Arends, JW
Hupperets, PSGJ
Hillen, HFP
Schouten, HC
Citation: Rlh. Jansen et al., Relevance of the expression of Bcl-2 in combination with p53 as a prognostic factor in breast cancer, ANTICANC R, 18(6A), 1998, pp. 4455-4462
Risultati:
1-15
|